TY - JOUR
T1 - Mania occurring during systemic lupus erythematosus relapse and its amelioration on clinical and neuroimaging follow-up
AU - Hirachi, T.
AU - Ishii, H.
AU - Tada, Y.
AU - Noguchi, T.
AU - Haraguchi, Y.
AU - Tateishi, H.
AU - Mizoguchi, Y.
AU - Kato, T. A.
AU - Kawashima, T.
AU - Monji, A.
N1 - Publisher Copyright:
© The Author(s), 2015.
PY - 2015/8/25
Y1 - 2015/8/25
N2 - Psychiatric manifestations of systemic lupus erythematosus (SLE) that are commonly preceded by organic syndromes include confusional states, anxiety disorder, cognitive dysfunction, mood disorder and psychosis. A 35-year-old woman was admitted to hospital with a relapse of SLE. Laboratory data were exacerbated, with some physical symptoms, and her primary psychiatric symptom was mania. The symptoms were reduced by treatment with prednisolone, methylprednisolone and aripiprazole. Magnetic resonance imaging and single-photon emission computed tomography (SPECT) using 123I-IMP was then performed and analyzed with three-dimensional stereotactic surface projection. This case emphasizes that SLE can commence with organic syndromes and relapse with predominantly psychiatric symptoms, and that the treatment efficacy may be confirmed using a follow-up of SPECT.
AB - Psychiatric manifestations of systemic lupus erythematosus (SLE) that are commonly preceded by organic syndromes include confusional states, anxiety disorder, cognitive dysfunction, mood disorder and psychosis. A 35-year-old woman was admitted to hospital with a relapse of SLE. Laboratory data were exacerbated, with some physical symptoms, and her primary psychiatric symptom was mania. The symptoms were reduced by treatment with prednisolone, methylprednisolone and aripiprazole. Magnetic resonance imaging and single-photon emission computed tomography (SPECT) using 123I-IMP was then performed and analyzed with three-dimensional stereotactic surface projection. This case emphasizes that SLE can commence with organic syndromes and relapse with predominantly psychiatric symptoms, and that the treatment efficacy may be confirmed using a follow-up of SPECT.
UR - http://www.scopus.com/inward/record.url?scp=84937905700&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937905700&partnerID=8YFLogxK
U2 - 10.1177/0961203315570161
DO - 10.1177/0961203315570161
M3 - Article
C2 - 25661832
AN - SCOPUS:84937905700
SN - 0961-2033
VL - 24
SP - 990
EP - 993
JO - Lupus
JF - Lupus
IS - 9
ER -